Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Canton Strategic Holdings Inc (CNTN)
Red Bank, NJ, US
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 EPS Ana. |
Dec 2027 1 EPS Ana. |
Dec 2028 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBITDA |
-12.21M
|
-42.05M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-12.21M
|
-42.08M
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-12.20M
est: -10.27M (-18.7%)
|
-35.92M
est: -226.27M (+84.1%)
|
-24.04M
-24.04M – -24.04M
+89.4% YoY
|
-28.84M
-28.84M – -28.84M
-20.0% YoY
|
-33.65M
-33.65M – -33.65M
-16.7% YoY
|
| SGA |
6.04M
|
17.03M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-9.41
est: -7.93 (-18.7%)
|
-1.12
est: -7.06 (+84.1%)
|
-0.75
-0.75 – -0.75
+89.4% YoY
|
-0.90
-0.90 – -0.90
-20.0% YoY
|
-1.05
-1.05 – -1.05
-16.7% YoY
|
Owner Earnings
Owner's Earnings history not available.
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ARK Blockchain & Fintech Innovation ETF ARKF | 0.12% | 882.9K | 0.75% |
| 2 | Horizon Kinetics Blockchain Development ETF BCDF | 0.00% | 1.0K | 0.85% |
| 3 | Global X - Russell 2000 ETF RSSL | 0.00% | 49.3K | 0.08% |
| 4 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.00% | 17.3K | 0.36% |
| 5 | ProShares - Ultra Russell2000 UWM | 0.00% | 4.2K | 1.07% |
| 6 | Vanguard Extended Market ETF VXF | 0.00% | 1.37M | 0.05% |
| 7 | ProShares - UltraPro Russell2000 URTY | 0.00% | 4.0K | 1.08% |
| 8 | ProShares - Hedge Replication ETF HDG | 0.00% | 102.34 | 0.95% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CNTN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
